| Dr Jamshid Alem Marvasti, MD | |
|
71 Haynes St, Mmh, Manchester, CT 06040-4131 | |
| (860) 643-1166 | |
| Not Available |
| Full Name | Dr Jamshid Alem Marvasti |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 53 Years |
| Location | 71 Haynes St, Manchester, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275592859 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 19515 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prospect Manchester Hospital, Inc. | 9234423625 | 16 |
News Archive
More women fighting cancers such as breast, lung, colorectal and ovarian can now help prevent the nausea and vomiting associated with their treatment of moderately emetogenic (vomit-inducing) cancer chemotherapy. Although new treatment entities have been developed in the past 10 years for control of chemically-induced nausea and vomiting, CINV remains a significant problem in the context of current practice.
Professor Lynn Fraser told the 21st annual conference of the European Society of Human Reproduction and Embryology today (Wednesday), that her previous research had shown that certain chemicals known to mimic the female sex hormone, oestrogen, could individually affect the correct functioning of mouse sperm, but now her new research showed that when the chemicals were combined they had an even stronger effect.
Results of a survey, commissioned by the Irish Department of Health and Children, show continuing strong public support for the smoke-free at work measure introduced on 29th March, 2004. The survey of 1,000 people was carried out recently by Lansdowne Market Research.
Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by the United States Food and Drug Administration for the potential treatment of patients with breast cancer.
› Verified 4 days ago
| Entity Name | Prospect Rockville Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205283538 PECOS PAC ID: 4880988211 Enrollment ID: O20160913001880 |
News Archive
More women fighting cancers such as breast, lung, colorectal and ovarian can now help prevent the nausea and vomiting associated with their treatment of moderately emetogenic (vomit-inducing) cancer chemotherapy. Although new treatment entities have been developed in the past 10 years for control of chemically-induced nausea and vomiting, CINV remains a significant problem in the context of current practice.
Professor Lynn Fraser told the 21st annual conference of the European Society of Human Reproduction and Embryology today (Wednesday), that her previous research had shown that certain chemicals known to mimic the female sex hormone, oestrogen, could individually affect the correct functioning of mouse sperm, but now her new research showed that when the chemicals were combined they had an even stronger effect.
Results of a survey, commissioned by the Irish Department of Health and Children, show continuing strong public support for the smoke-free at work measure introduced on 29th March, 2004. The survey of 1,000 people was carried out recently by Lansdowne Market Research.
Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by the United States Food and Drug Administration for the potential treatment of patients with breast cancer.
› Verified 4 days ago
| Entity Name | Prospect Manchester Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316394638 PECOS PAC ID: 9234423625 Enrollment ID: O20160926000570 |
News Archive
More women fighting cancers such as breast, lung, colorectal and ovarian can now help prevent the nausea and vomiting associated with their treatment of moderately emetogenic (vomit-inducing) cancer chemotherapy. Although new treatment entities have been developed in the past 10 years for control of chemically-induced nausea and vomiting, CINV remains a significant problem in the context of current practice.
Professor Lynn Fraser told the 21st annual conference of the European Society of Human Reproduction and Embryology today (Wednesday), that her previous research had shown that certain chemicals known to mimic the female sex hormone, oestrogen, could individually affect the correct functioning of mouse sperm, but now her new research showed that when the chemicals were combined they had an even stronger effect.
Results of a survey, commissioned by the Irish Department of Health and Children, show continuing strong public support for the smoke-free at work measure introduced on 29th March, 2004. The survey of 1,000 people was carried out recently by Lansdowne Market Research.
Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by the United States Food and Drug Administration for the potential treatment of patients with breast cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jamshid Alem Marvasti, MD 71 Haynes St, Mmh, Manchester, CT 06040-4131 Ph: (860) 643-1166 | Dr Jamshid Alem Marvasti, MD 71 Haynes St, Mmh, Manchester, CT 06040-4131 Ph: (860) 643-1166 |
News Archive
More women fighting cancers such as breast, lung, colorectal and ovarian can now help prevent the nausea and vomiting associated with their treatment of moderately emetogenic (vomit-inducing) cancer chemotherapy. Although new treatment entities have been developed in the past 10 years for control of chemically-induced nausea and vomiting, CINV remains a significant problem in the context of current practice.
Professor Lynn Fraser told the 21st annual conference of the European Society of Human Reproduction and Embryology today (Wednesday), that her previous research had shown that certain chemicals known to mimic the female sex hormone, oestrogen, could individually affect the correct functioning of mouse sperm, but now her new research showed that when the chemicals were combined they had an even stronger effect.
Results of a survey, commissioned by the Irish Department of Health and Children, show continuing strong public support for the smoke-free at work measure introduced on 29th March, 2004. The survey of 1,000 people was carried out recently by Lansdowne Market Research.
Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by the United States Food and Drug Administration for the potential treatment of patients with breast cancer.
› Verified 4 days ago
Dr. Allana R Lee, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 71 Haynes St, Manchester, CT 06040 Phone: 860-646-1222 | |
Michael John Dewberry, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 444 Center St, Manchester, CT 06040 Phone: 860-646-3888 Fax: 860-645-4132 | |
Manpreet Kaur, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 71 Haynes St, Manchester, CT 06040 Phone: 860-647-6827 Fax: 860-533-3452 | |
Dr. Constantine Zariphes, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 150 N Main St, Manchester, CT 06042 Phone: 860-533-3434 Fax: 860-647-6829 | |
Dr. Anees Ahmed, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 357 E Center St, #2, Manchester, CT 06040 Phone: 860-649-1178 | |
Jonathan L Chasen, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 444 Center St, Manchester, CT 06040 Phone: 860-646-3888 Fax: 860-645-4132 | |
Dr. Joseph E. Podolski, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 71 Haynes St, Department Of Psychiatry, Manchester, CT 06040 Phone: 860-647-6831 |